Multiple Organ Dysfunction Syndrome in Humans and Animals

Journal of Veterinary Internal Medicine

Volumn 28, Issue 4, 2014, Pages 1141-1151

  Osterbur, K ^a   Mann, F A ^b   Kuroki, K ^b   Declue, A ^b  

^a Pittsburgh Veterinary Specialty and Emergency Center ^*  (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Acute respiratory distress syndrome; Disseminated intravascular coagulation; Multiple organ failure; Sepsis

Indexed keywords

ANIMAL; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; GASTROINTESTINAL TRACT; HUMAN; KIDNEY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; VETERINARY;

ANIMALS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; GASTROINTESTINAL TRACT; HUMANS; KIDNEY; MULTIPLE ORGAN FAILURE;

EID: 84904282238     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12364     Document Type: Review

References (174)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
2. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-1655.
3. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-134.
4. Tran DD, Groeneveld AB, van der Meulen J, et al. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med 1990;18:474-479.
5. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
6. Kenney EM, Rozanski EA, Rush JE, et al. Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003-2007). J Am Vet Med Assoc 2010;236:83-87.
7. Simpson SA, Syring R, Otto CM. Severe blunt trauma in dogs: 235 cases (1997-2003). J Vet Emerg Crit Care (San Antonio) 2009;19:588-602.
8. Marshall JC. Critical illness is an iatrogenic disorder. Crit Care Med 2011;38:S582-S589.
9. Cheadle WG, Turina M. Infection and organ failure in the surgical patient: A tribute to seminal contributions by Hiram C. Polk, Jr, M.D. Am J Surg 2005;190:173-177.
10. Skillman JJ, Bushnell LS, Goldman H, et al. Respiratory failure, hypotension, sepsis, and jaundice. A clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach. Am J Surg 1969;117:523-530.
11. Tilney NL, Bailey GL, Morgan AP. Sequential system failure after rupture of abdominal aortic aneurysms: An unsolved problem in postoperative care. Ann Surg 1973;178:117-122.
12. Fry DE, Pearlstein L, Fulton RL, et al. Multiple system organ failure. The role of uncontrolled infection. Arch Surg 1980;115:136-140.
13. Polk HC Jr, Shields CL. Remote organ failure: A valid sign of occult intra-abdominal infection. Surgery 1977;81:310-313.
14. Bell RC, Coalson JJ, Smith JD, et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983;99:293-298.
15. Goris RJ, Boekhorst TP, Nuytinck JK, et al. Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 1985;120:1109-1115.
16. Norton LW. Does drainage of intraabdominal pus reverse multiple organ failure? Am J Surg 1985;149:347-350.
17. Marshall JC, Christou NV, Horn R, et al. The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. Arch Surg 1988;123:309-315.
18. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006;34:344-353.
19. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
20. Craft EM, Powell LL. The use of canine-specific albumin in dogs with septic peritonitis. J Vet Emerg Crit Care (San Antonio) 2012;22:631-639.
21. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228.
22. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 1995;75:257-277.
23. Mizock BA. The multiple organ dysfunction syndrome. Dis Mon 2009;55:476-526.
24. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008;8:776-787.
25. Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007;81:1-5.
26. Bone RC. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996;125:680-687.
27. Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 2008;29:617-625.
28. Lewis DH, Chan DL, Pinheiro D, et al. The immunopathology of sepsis: Pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells. J Vet Intern Med 2012;26:457-482.
29. Maeda K, Sakonju I, Kanda A, et al. Priming effects of lipopolysaccharide and inflammatory cytokines on canine granulocytes. J Vet Med Sci 2009;72:55-60.
30. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: Pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 1998;94:461-471.
31. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
32. Fink MP. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001;17:219-237.
33. Kim JS, He L, Qian T, et al. Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr Mol Med 2003;3:527-535.
34. Fink M. Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl 1997;110:87-95.
35. Brealey D, Karyampudi S, Jacques TS, et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004;286:R491-R497.
36. Fredriksson K, Rooyackers O. Mitochondrial function in sepsis: Respiratory versus leg muscle. Crit Care Med 2007;35:S449-S453.
37. Crouser ED, Julian MW, Blaho DV, et al. Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002;30:276-284.
38. Larche J, Lancel S, Hassoun SM, et al. Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. J Am Coll Cardiol 2006;48:377-385.
39. Singer PM, De Santis V, Vitale D, et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inaflammation. Lancet 2004;364:545-548.
40. Khadaroo RG, Marshall JC. ARDS and the multiple organ dysfunction syndrome. Common mechanisms of a common systemic process. Crit Care Clin 2002;18:127-141.
41. Aronsohn A, Jensen D. Hepatobiliary manifestations of critically ill and postoperative patients. Clin Liver Dis 2011;15:183-197.
42. Maynard ND, Bihari DJ, Dalton RN, et al. Liver function and splanchnic ischemia in critically ill patients. Chest 1997;111:180-187.
43. Szabo G, Romics L Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002;6:1045-1066, x.
44. Kramer L, Jordan B, Druml W, et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients-A prospective multicenter study. Crit Care Med 2007;35:1099-1104.
45. Bestati N, Leteurtre S, Duhamel A, et al. Differences in organ dysfunctions between neonates and older children: A prospective, observational, multicenter study. Crit Care 2010;14:R202.
46. Harbrecht BG, Doyle HR, Clancy KD, et al. The impact of liver dysfunction on outcome in patients with multiple injuries. Am Surg 2001;67:122-126.
47. Welzl C, Leisewitz AL, Jacobson LS, et al. Systemic inflammatory response syndrome and multiple-organ damage/dysfunction in complicated canine babesiosis. J S Afr Vet Assoc 2001;72:158-162.
48. Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999;25:686-696.
49. Cook R, Cook D, Tilley J, et al. Multiple organ dysfunction: Baseline and serial component scores. Crit Care Med 2001;29:2046-2050.
50. Matijatko V, Kis I, Torti M, et al. Septic shock in canine babesiosis. Vet Parasitol 2009;162:263-270.
51. Osterbur K, Whitehead Z, Sharp CR, et al. Plasma nitrate/nitrite concentrations in dogs with naturally developing sepsis and non-infectious forms of the systemic inflammatory response syndrome. Vet Rec 2011;169:554.
52. Blank R, Napolitano LM. Epidemiology of ARDS and ALI. Crit Care Clin 2011;27:439-458.
53. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: Incidence and risk factors. Blood 2012;119:1757-1767.
54. Pelosi P, Caironi P, Gattinoni L. Pulmonary and extrapulmonary forms of acute respiratory distress syndrome. Semin Respir Crit Care Med 2001;22:259-268.
55. Pelosi P, D'Onofrio D, Chiumello D, et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl 2003;42:48s-56s.
56. Lees GE, Suter PF, Johnson GC. Pulmonary edema in a dog with acute pancreatitis and cardiac disease. J Am Vet Med Assoc 1978;172:690-696.
57. Turk J, Miller M, Brown T, et al. Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987-1988). J Am Vet Med Assoc 1990;196:771-773.
58. Johnson RP, Huxtable CR. Paraquat poisoning in a dog and cat. Vet Rec 1976;98:189-191.
59. Gee BR, Farrow CS, White RJ, et al. Paraquat toxicity resulting in respiratory distress syndrome in a dog. J Am Anim Hosp Assoc 1978;14:256-263.
60. Parekh D, Dancer RC, Thickett DR. Acute lung injury. Clin Med 2012;11:615-618.
61. Villar J. What is the acute respiratory distress syndrome? Respir Care 2011;56:1539-1545.
62. Mikkelsen ME, Shah CV, Meyer NJ, et al. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock 2013;40:375-381.
63. Agarwal R, Srinivas R, Nath A, et al. Is the mortality higher in the pulmonary vs the extrapulmonary ARDS? A meta analysis. Chest 2008;133:1463-1473.
64. Haas SA, Davidow E. Successful management of saltwater submersion injury in a dog using mechanical ventilation. J Vet Emerg Crit Care 2008;18:646-653.
65. Walker T, Tidwell AS, Rozanski EA, et al. Imaging diagnosis: Acute lung injury following massive bee envenomation in a dog. Vet Radiol Ultrasound 2005;46:300-303.
66. Kelmer E, Love LC, Declue AE, et al. Successful treatment of acute respiratory distress syndrome in 2 dogs. Can Vet J 2012;53:167-173.
67. Hopper K, Haskins SC, Kass PH, et al. Indications, management, and outcome of long-term positive-pressure ventilation in dogs and cats: 148 cases (1990-2001). J Am Vet Med Assoc 2007;230:64-75.
68. Ukleja A. Altered GI motility in critically Ill patients: Current understanding of pathophysiology, clinical impact, and diagnostic approach. Nutr Clin Pract 2010;25:16-25.
69. Hackett TB. Gastrointestinal complications of critical illness in small animals. Vet Clin North Am Small Anim Pract 2011;41:759-766, vi.
70. Chapman MJ, Nguyen NQ, Deane AM. Gastrointestinal dysmotility: Clinical consequences and management of the critically ill patient. Gastroenterol Clin North Am 2011;40:725-739.
71. Deitch EA. Gut-origin sepsis: Evolution of a concept. Surgeon 2012;10:350-356.
72. Wiest R, Rath HC. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 2003;17:397-425.
73. Hayakawa M, Asahara T, Henzan N, et al. Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci 2011;56:2361-2365.
74. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-519.
75. Farrell CP, Barr M, Mullin JM, et al. Epithelial barrier leak in gastrointestinal disease and multiorgan failure. J Epithel Biol Pharmacol 2012;5:13-18.
76. Ambromovage AM, Shah U, Howard JM. Xylose and inulin absorption. From the small intestine of dogs following endotoxin shock. Arch Surg 1971;102:496-500.
77. Jackman BJ, Eades SC, Moore JN, et al. Differential effects of an infusion of endotoxin on proximal and distal feline jejunal permeability. J Endotoxin Res 1996;3:77-86.
78. Cullen JJ, Hemann LL, Ephgrave KS, et al. Endotoxin temporarily impairs canine jejunal absorption of water, electrolytes, and glucose. J Gastrointest Surg 1997;1:286-291.
79. Cullen JJ, Caropreso DK, Ephgrave KS, et al. The effect of endotoxin on canine jejunal motility and transit. J Surg Res 1997;67:54-57.
80. Cullen JJ, Spates ST, Ephgrave KS, et al. Endotoxin temporarily impairs canine colonic absorption of water and sodium. J Surg Res 1998;74:34-38.
81. Spates ST, Cullen JJ, Ephgrave KS, et al. Effect of endotoxin on canine colonic motility and transit. J Gastrointest Surg 1998;2:391-398.
82. Ferreira AM, Sakr Y. Organ dysfunction: General approach, epidemiology, and organ failure scores. Semin Respir Crit Care Med 2011;32:543-551.
83. Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012;30:149-173.
84. Hoesel LM, Niederbichler AD, Ward PA. Complement-related molecular events in sepsis leading to heart failure. Mol Immunol 2007;44:95-102.
85. Hassoun SM, Marechal X, Montaigne D, et al. Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction. Crit Care Med 2008;36:2590-2596.
86. Kao YH, Chen YC, Cheng CC, et al. Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2 + -ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med 2009;38:217-222.
87. Natanson C, Danner RL, Elin RJ, et al. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 1989;83:243-251.
88. Walley KR, Hebert PC, Wakai Y, et al. Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs. J Appl Physiol 1994;76:1060-1067.
89. Stein B, Frank P, Schmitz W, et al. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 1996;28:1631-1639.
90. Natanson C, Eichenholz PW, Danner RL, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823-832.
91. Pathan N, Hemingway CA, Alizadeh AA, et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004;363:203-209.
92. Khadour FH, Panas D, Ferdinandy P, et al. Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol 2002;283:H1108-H1115.
93. Parrillo JE, Burch C, Shelhamer JH, et al. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985;76:1539-1553.
94. Ferdinandy P, Danial H, Ambrus I, et al. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 2000;87:241-247.
95. Nelson OL, Thompson PA. Cardiovascular dysfunction in dogs associated with critical illnesses. J Am Anim Hosp Assoc 2006;42:344-349.
96. Dickinson AE, Rozanski EA, Rush JE. Reversible myocardial depression associated with sepsis in a dog. J Vet Intern Med 2007;21:1117-1120.
97. Rohde JM, Odden AJ, Bonham C, et al. The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med 2013;8:243-247.
98. Ogura H, Gando S, Saitoh D, et al. Epidemiology of severe sepsis in Japanese intensive care units: A prospective multicenter study. J Infect Chemother 2014;20:157-162.
99. Guidet B, Aegerter P, Gauzit R, et al. Incidence and impact of organ dysfunctions associated with sepsis. Chest 2005;127:942-951.
100. Burkitt JM, Haskins SC, Nelson RW, et al. Relative adrenal insufficiency in dogs with sepsis. J Vet Intern Med 2007;21:226-231.
101. Conti-Patara A, de Araujo Caldeira J, de Mattos-Junior E, et al. Changes in tissue perfusion parameters in dogs with severe sepsis/septic shock in response to goal-directed hemodynamic optimization at admission to ICU and the relation to outcome. J Vet Emerg Crit Care (San Antonio) 2012;22:409-418.
102. Bentley AM, Otto CM, Shofer FS. Comparison of dogs with septic peritonitis: 1988-1993 versus 1999-2003: Retrospective Study. J Vet Emerg Crit Care 2007;17:391-398.
103. Costello MF, Drobatz KJ, Aronson LR, et al. Underlying cause, pathophysiologic abnormalities, and response to treatment in cats with septic peritonitis: 51 cases (1990-2001). J Am Vet Med Assoc 2004;225:897-902.
104. Ruthrauff CM, Smith J, Glerum L. Primary bacterial septic peritonitis in cats: 13 cases. J Am Anim Hosp Assoc 2009;45:268-276.
105. Lee JA, Drobatz KJ, Koch MW, et al. Indications for and outcome of positive-pressure ventilation in cats: 53 cases (1993-2002). J Am Vet Med Assoc 2005;226:924-931.
106. Ivanyi B, Thoenes W. Microvascular injury and repair in acute human bacterial pyelonephritis. Virchows Arch A Pathol Anat Histopathol 1987;411:257-265.
107. Kak V. Mediators of systemic inflammatory response syndrome and the role of recombinant activated protein C in sepsis syndrome. Infect Dis Clin North Am 2011;25:835-850.
108. Levi M. The coagulant response in sepsis. Clin Chest Med 2008;29:627-642, viii.
109. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-592.
110. Aird WC. The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc 2003;78:869-881.
111. Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992;101:816-823.
112. Fischer CM, Yano K, Aird WC, et al. Abnormal coagulation tests obtained in the emergency department are associated with mortality in patients with suspected infection. J Emerg Med 2012;42:127-132.
113. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units. J Am Med Assoc 1995;274:968-974.
114. Mavrommatis AC, Theodoridis T, Orfanidou A, et al. Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000;28:451-457.
115. de Laforcade AM, Freeman LM, Shaw SP, et al. Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 2003;17:674-679.
116. Otto CM, Drobatz KJ, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997;11:65-70.
117. Rogers CL, Rozanski EA. Von Willebrand factor antigen concentration in dogs with sepsis. J Vet Intern Med 2010;24:229-230.
118. Kuzi S, Segev G, Haruvi E, et al. Plasma antithrombin activity as a diagnostic and prognostic indicator in dogs: A retrospective study of 149 dogs. J Vet Intern Med 2010;24:587-596.
119. de Laforcade AM, Rozanski EA, Freeman LM, et al. Serial evaluation of protein C and antithrombin in dogs with sepsis. J Vet Intern Med 2008;22:26-30.
120. Estrin MA, Wehausen CE, Jessen CR, et al. Disseminated intravascular coagulation in cats. J Vet Intern Med 2006;20:1334-1339.
121. Thomas JS, Green RA. Clotting times and antithrombin III activity in cats with naturally developing diseases: 85 cases (1984-1994). J Am Vet Med Assoc 1998;213:1290-1295.
122. Peterson JL, Couto CG, Wellman ML. Hemostatic disorders in cats: A retrospective study and review of the literature. J Vet Intern Med 1995;9:298-303.
123. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
124. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005;365:417-430.
125. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999;27:1230-1251.
126. Rosen S, Heyman SN. Difficulties in understanding human "acute tubular necrosis": Limited data and flawed animal models. Kidney Int 2001;60:1220-1224.
127. Langenberg C, Bagshaw SM, May CN, et al. The histopathology of septic acute kidney injury: A systematic review. Crit Care 2008;12:R38.
128. Messmer UK, Winkel G, Briner VA, et al. Glucocorticoids potently block tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptotic cell death in bovine glomerular endothelial cells upstream of caspase 3 activation. Br J Pharmacol 1999;127:1633-1640.
129. Chvojka J, Sykora R, Karvunidis T, et al. New developments in septic acute kidney injury. Physiol Res 2010;59:859-869.
130. Brenner M, Schaer GL, Mallory DL, et al. Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 1990;98:170-179.
131. Ravikant T, Lucas CE. Renal blood flow distribution in septic hyperdynamic pigs. J Surg Res 1977;22:294-298.
132. Langenberg C, Wan L, Egi M, et al. Renal blood flow in experimental septic acute renal failure. Kidney Int 2006;69:1996-2002.
133. Wan L, Bagshaw SM, Langenberg C, et al. Pathophysiology of septic acute kidney injury: What do we really know? Crit Care Med 2008;36:S198-S203.
134. Chertow GM, Christiansen CL, Cleary PD, et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 1995;155:1505-1511.
135. Chertow GM, Lazarus JM, Paganini EP, et al. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol 1998;9:692-698.
136. Metnitz PG, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051-2058.
137. Mehta RL, Pascual MT, Gruta CG, et al. Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 2002;13:1350-1357.
138. Wang HE, Muntner P, Chertow GM, et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 2012;35:349-355.
139. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: A multinational, multicenter study. J Am Med Assoc 2005;294:813-818.
140. Bagshaw SM, Lapinsky S, Dial S, et al. Acute kidney injury in septic shock: Clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009;35:871-881.
141. Podoll AS, Kozar R, Holcomb JB, et al. Incidence and outcome of early acute kidney injury in critically-ill trauma patients. PLoS One 2013;8:1-5.
142. Thoen ME, Kerl ME. Characterization of acute kidney injury in hospitalized dogs and evaluation of a veterinary acute kidney injury staging system. J Vet Emerg Crit Care (San Antonio) 2012;21:648-657.
143. Iacobone E, Bailly-Salin J, Polito A, et al. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 2009;37:S331-S336.
144. Sonneville R, Verdonk F, Rauturier C, et al. Understanding brain dysfunction in sepsis. Annals of Intensive Care 2013;3:1-11.
145. Lamar CD, Hurley RA, Taber KH. Sepsis-associated encephalopathy: Review of the neuropsychiatric manifestations and cognitive outcome. J Neuropsychiatry Clin Neurosci 2011;23:237-241.
146. Sharshar T, Annane D, de la Grandmaison GL, et al. The neuropathology of septic shock. Brain Pathol 2004;14:21-33.
147. Kafa IM, Bakirci S, Uysal M, et al. Alterations in the brain electrical activity in a rat model of sepsis-associated encephalopathy. Brain Res 2010;1354:217-226.
148. Sprung CL, Peduzzi PN, Shatney CH, et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 1990;18:801-806.
149. Hopkins RO, Weaver LK, Chan KJ, et al. Quality of life, emotional, and cognitive function following acute respiratory distress syndrome. J Int Neuropsychol Soc 2004;10:1005-1017.
150. Bronner MB, Knoester H, Sol JJ, et al. An explorative study on quality of life and psychological and cognitive function in pediatric survivors of septic shock. Pediatr Crit Care Med 2009;10:636-642.
151. Scragg P, Jones A, Fauvel N. Psychological problems following ICU treatment. Anaesthesia 2001;56:9-14.
152. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009;135:181-193.
153. Meduri GU, Muthiah MP, Carratu P, et al. Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005;12:321-338.
154. Maxime V, Siami S, Annane D. Metabolism modulators in sepsis: The abnormal pituitary response. Crit Care Med 2007;35:S596-S601.
155. Graves KK, Faraklas I, Cochran A. Identification of risk factors associated with critical illness related corticosteroid insufficiency in burn patients. J Burn Care Res 2012;33:330-335.
156. Bruno JJ, Hernandez M, Ghosh S, et al. Critical illness-related corticosteroid insufficiency in cancer patients. Support Care Cancer 2012;20:1159-1167.
157. Walker ML, Owen PS, Sampson C, et al. Incidence and outcomes of critical illness-related corticosteroid insufficiency in trauma patients. Am Surg 2011;77:579-585.
158. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. J Am Med Assoc 2002;288:862-871.
159. Baldwin WA, Allo M. Occult hypoadrenalism in critically ill patients. Arch Surg 1993;128:673-676.
160. Oppert M, Schindler R, Husung C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005;33:2457-2464.
161. Ranzani OT, Ferrer M, Esperatti M, et al. Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia. Crit Care Med 2012;40:2552-2561.
162. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-124.
163. Cohen J, Venkatesh B. Relative adrenal insufficiency in the intensive care population; background and critical appraisal of the evidence. Anaesth Intensive Care 2010;38:425-436.
164. Martin LG, Groman RP, Fletcher DJ, et al. Pituitary-adrenal function in dogs with acute critical illness. J Am Vet Med Assoc 2008;233:87-95.
165. Peyton JL, Burkitt JM. Critical illness-related corticosteroid insufficiency in a dog with septic shock. J Vet Emerg Crit Care (San Antonio) 2009;19:262-268.
166. Wong DM, Vo DT, Alcott CJ, et al. Baseline plasma cortisol and ACTH concentrations and response to low-dose ACTH stimulation testing in ill foals. J Am Vet Med Assoc 2009;234:126-132.
167. Prittie JE, Barton LJ, Peterson ME, et al. Pituitary ACTH and adrenocortical secretion in critically ill dogs. J Am Vet Med Assoc 2002;220:615-619.
168. Durkan S, De Laforcade A, Rozanski E, et al. Suspected relative adrenal insufficiency in a critically ill cat. J Vet Emerg Crit Care 2007;17:197-201.
169. Nfor TK, Walsh TS, Prescott RJ. The impact of organ failures and their relationship with outcome in intensive care: Analysis of a prospective multicentre database of adult admissions. Anaesthesia 2006;61:731-738.
170. Umegaki T, Ikai H, Imanaka Y. The impact of acute organ dysfunction on patients' mortality with severe sepsis. J Anaesthesiol Clin Pharmacol 2011;27:180-184.
171. Typpo KV, Petersen NJ, Hallman DM, et al. Day 1 multiple organ dysfunction syndrome is associated with poor functional outcome and mortality in the pediatric intensive care unit. Pediatr Crit Care Med 2009;10:562-570.
172. Danai PA, Moss M, Mannino DM, et al. The epidemiology of sepsis in patients with malignancy. Chest 2006;129:1432-1440.
173. Esper AM, Moss M, Lewis CA, et al. The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med 2006;34:2576-2582.
174. Matijatko V, Kis I, Torti M, et al. Systemic inflammatory response syndrome and multiple organ dysfunction syndrome in canine babesiosis. Veterinarski Arhiv 2010;80:611-626.